MMWR News Synopsis

Multistate Outbreak of Salmonella Infections Linked to Raw Turkey Products — United States, 2017–2019

CDC Media Relations
404-639-3286

As the holiday season approaches, this final report on a recent outbreak of Salmonella infections linked to raw turkey products serves as a reminder to handle raw turkey safely and to cook it thoroughly to prevent foodborne illness. During 2018 and early 2019, CDC and public health partners investigated an outbreak of Salmonella Reading infections linked to raw turkey products. The outbreak was widespread, sickening 356 people in 42 states and the District of Colombia. Investigators found the outbreak strain in several brands and types of raw turkey products for people and pets, suggesting contamination was widespread in the turkey supply chain. Because no single source of turkey was identified, CDC and partners worked with the National Turkey Federation, an industry group, to identify and address issues leading to this contamination. New cases continue to be identified since the investigation ended in April 2019, underscoring the need for additional preventive action by the turkey industry and highlighting the importance of handling and cooking raw turkey safely.

Traumatic Brain Injury–Related Deaths by Race/Ethnicity, Sex, Intent, and Mechanism of Injury — United States, 2000–2017

CDC Media Relations
404-639-3286

Traumatic brain injury (TBI) affects the lives of millions of Americans each year, with different groups at increased risk for the leading categories of TBI-related death. More than 61,000 TBI-related deaths occurred in the United States in 2017. During the study period of 2000-2017, suicide and falls surpassed motor vehicle crashes as the leading categories of TBI-related death. Males and American Indians/Alaska Natives experienced the highest rates of TBI-related death. Evidence-based prevention strategies can reduce many of the most common ways people suffer a TBI. Expanded use of these strategies could prevent many TBIs and save lives.

State-Specific Obesity Prevalence Among Enrollees Aged 2–4 Years in the Special Supplemental Nutrition Program for Women, Infants, and Children — United States, 2010–2016

CDC Media Relations
404-639-3286

This new CDC study found significant declines in obesity among young children in families enrolled in Special Supplemental Nutrition Programs for Women, Infants, and Children (WIC). More states and U.S. territories show declines in obesity among young children enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). Between 2010 -2016, 41 WIC state and territory agencies showed significant declines in obesity among young children, aged 2-4 years, from low-income families. In 2016, obesity prevalence among young children enrolled in WIC varied from 7.8% to 19.8%. Obesity decreased by more than 3% percent in seven WIC state and territorial agencies (New Jersey, New Mexico, Utah, Virginia, Guam, Northern Mariana Islands, and Puerto Rico). Efforts supporting early child nutrition, such as the revised WIC food packages, may have contributed to this decrease.

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019

CDC Media Relations
404-639-3286

Tafenoquine is a new, safe, and effective drug option both for malaria prevention when traveling and as part of a treatment regimen for malaria. About 2,000 cases of malaria, a serious and sometimes deadly infection spread by mosquitoes, are still reported in the United States each year, mostly among travelers. Prevention of infection through medications and/or mosquito avoidance, as well as appropriate diagnosis and effective treatment, are critical. Tafenoquine is a new, safe, and effective drug option for malaria prevention and treatment. This report is the first national summary of the published efficacy and safety evidence for the recommended doses for both prevention and treatment and provides guidance for the use of tafenoquine in the United States.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥ 65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

CDC Media Relations
404-639-3286

CDC now recommends pneumococcal conjugate vaccine (PCV13) based on shared clinical decision making for adults 65 years or older who do not have an immunocompromising condition, cerebrospinal fluid (CSF) leak, or cochlear implant and who have not previously received PCV13. Due to decreasing rates of infection after several years of widespread vaccination CDC no longer recommends routine PCV13 use among all adults aged 65 years or older. Instead, older adults who have not received PCV13 and do not have an immunocompromising condition, CSF leak, or cochlear implant should discuss PCV13 vaccination with their vaccine providers to decide if PCV13 might be appropriate for them. Considerations may include likelihood of exposure due to traveling to or living in communities with higher rates of disease caused by vaccine strains and, if exposed, their risk of developing pneumococcal disease due to their underlying medical conditions. CDC continues to recommend PCV13 for adults, including older adults, who have an immunocompromising condition, CSF leak, or cochlear implant, as well as PPSV23 for all adults aged 65+ years.

Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

• Percentage of Currently Employed Adults Aged 18–64 Years Who Have Paid Sick Leave, by Poverty Status — National Health Interview Survey, United States, 2008 and 2018

###

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

CDC works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.